Stem Cell-Derived Islets vs. Primary Islets: How They React to Low Oxygen
A new study reveals that stem cell-derived islets and primary human islets respond differently to low oxygen levels, which could impact the success of cell replacement therapies for Type 1 diabetes.
Key takeaways
- Stem cell-derived islets are more vulnerable to low oxygen levels than primary human islets.
- The two types of islets react to hypoxia in distinct ways, leading to different outcomes.
- Understanding these differences could help develop targeted therapies to improve the success of cell replacement treatments.
What Happens When Islets Are Exposed to Low Oxygen
When stem cell-derived islets and primary human islets are exposed to low oxygen levels, they respond in different ways. Researchers conducted a study to compare the two types of islets under these conditions.
They found that primary human islets suppress genes related to insulin production and shift towards metabolic quiescence, a state where they conserve energy.
Stem Cell-Derived Islets React Differently
In contrast, stem cell-derived islets exhibit an unstable, plastic phenotype under low oxygen levels. They shift towards glycolysis and activate pro-apoptotic pathways.
This means that they are more prone to cell death and may not function properly in the body.
Implications for Cell Replacement Therapies
The study's findings have significant implications for cell replacement therapies, which aim to treat Type 1 diabetes by replacing damaged islets with healthy ones.
Understanding how stem cell-derived islets and primary human islets respond to low oxygen levels could help researchers develop targeted therapies to improve the success of these treatments.
Evidence label
Source: Scientific reports. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.